Skip to main content
. 2015 Mar 14;21(10):3072–3084. doi: 10.3748/wjg.v21.i10.3072

Figure 7.

Figure 7

Adequate general symptoms improvement. A: Individual and pooled relative risk in studies comparing probiotics and placebo irritable bowel syndrome patients; B: Heterogeneity indicators for the studies; C: Publication bias indicators.